The store will not work correctly when cookies are disabled.
2,6-Difluoro-3-{2-[3-(trifluoromethyl)phenyl]ethoxy}benzamide
ID: ALA5090219
PubChem CID: 166631443
Max Phase: Preclinical
Molecular Formula: C16H12F5NO2
Molecular Weight: 345.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCc2cccc(C(F)(F)F)c2)c1F
Standard InChI: InChI=1S/C16H12F5NO2/c17-11-4-5-12(14(18)13(11)15(22)23)24-7-6-9-2-1-3-10(8-9)16(19,20)21/h1-5,8H,6-7H2,(H2,22,23)
Standard InChI Key: DGIMPRHGNKTJOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
32.3236 -8.6163 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.1446 -8.6306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7464 -7.9124 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.4144 -10.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1106 -11.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8254 -10.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8412 -9.8688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1363 -9.4471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4244 -9.8440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8626 -8.2322 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.1710 -9.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1699 -10.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8779 -11.0719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5876 -10.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5848 -9.8398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8762 -9.4345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8737 -8.6174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5802 -8.2066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1648 -8.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2960 -11.0700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0030 -10.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2909 -9.4285 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.4632 -9.4350 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.7114 -11.0677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 2 1 0
2 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
17 18 1 0
17 19 2 0
14 20 1 0
20 21 1 0
15 22 1 0
11 23 1 0
21 24 1 0
24 4 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 345.27 | Molecular Weight (Monoisotopic): 345.0788 | AlogP: 3.70 | #Rotatable Bonds: 5 |
Polar Surface Area: 52.32 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 3.84 | CX LogD: 3.84 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.84 | Np Likeness Score: -1.25 |
References
1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781] [10.1021/acs.jmedchem.0c02207] |